Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone.
about
An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
P2860
Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Intermittent granulocyte colon ...... nalidomide plus dexamethasone.
@ast
Intermittent granulocyte colon ...... nalidomide plus dexamethasone.
@en
type
label
Intermittent granulocyte colon ...... nalidomide plus dexamethasone.
@ast
Intermittent granulocyte colon ...... nalidomide plus dexamethasone.
@en
prefLabel
Intermittent granulocyte colon ...... nalidomide plus dexamethasone.
@ast
Intermittent granulocyte colon ...... nalidomide plus dexamethasone.
@en
P2093
P2860
P1433
P1476
Intermittent granulocyte colon ...... nalidomide plus dexamethasone.
@en
P2093
Andrew Winter
Christine Chen
Donna E Reece
Elizabeth Yeboah
Esther Masih-Khan
Haowei Linda Sun
Vishal Kukreti
P2860
P304
P356
10.3109/10428194.2014.915544
P577
2014-07-07T00:00:00Z